Evommune EVMN Loss On Issuance Of Preferred Stock Derivative Liability
Loss On Issuance Of Preferred Stock Derivative Liability at other companies
Other financials
Where this comes from
Reported directly by Evommune in its filing.
Tagged under the XBRL concept meha:LossOnIssuanceOfPreferredStockDerivativeLiability.
The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evommune 's loss on issuance of preferred stock derivative liability.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evommune 's loss on issuance of preferred stock derivative liability?
- Evommune (EVMN) reported loss on issuance of preferred stock derivative liability of $6.31M in Q1 2026.
- How has Evommune 's loss on issuance of preferred stock derivative liability changed year-over-year?
- Evommune 's loss on issuance of preferred stock derivative liability increased by 376.8% year-over-year, from $1.32M to $6.31M.
- What does loss on issuance of preferred stock derivative liability mean?
- Captures the non-cash expense recognized upon the initial issuance of preferred stock that contains embedded derivative features. This reflects the accounting valuation of complex equity instruments that must be bifurcated and measured at fair value. It provides insight into the cost of capital associated with structured financing arrangements.